The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis
Open accessAbstract
Signal transducer and activator of transcription (STAT)5 is constitutively activated in BCR/ ABL-expressing cells, but the mechanisms and functional consequences of such activation are unknown. We show here that BCR/ABL induces phosphorylation and activation of STAT5 by a mechanism that requires the BCR/ABL Src homology (SH)2 domain and the proline-rich binding site of the SH3 domain. Upon expression in 32Dcl3 growth factor–dependent myeloid precursor cells, STAT5 activation–deficient BCR/ABL SH3+SH2 domain mutants functioned as tyrosine kinase and activated Ras, but failed to protect from apoptosis induced by withdrawal of interleukin 3 and/or serum and did not induce leukemia in severe combined immunodeficiency mice. In complementation assays, expression of a dominant-active STAT5B mutant (STAT5B-DAM), but not wild-type STAT5B (STAT5B-WT), in 32Dcl3 cells transfected with STAT5 activation–deficient BCR/ABL SH3+SH2 mutants restored protection from apoptosis, stimulated growth factor–independent cell cycle progression, and rescued the leukemogenic potential in mice. Moreover, expression of a dominant-negative STAT5B mutant (STAT5B-DNM) in 32Dcl3 cells transfected with wild-type BCR/ABL inhibited apoptosis resistance, growth factor–independent proliferation, and the leukemogenic potential of these cells. In retrovirally infected mouse bone marrow cells, expression of STAT5B-DNM inhibited BCR/ABL-dependent transformation. Moreover, STAT5B-DAM, but not STAT5B-WT, markedly enhanced the ability of STAT5 activation–defective BCR/ABL SH3+SH2 mutants to induce growth factor–independent colony formation of primary mouse bone marrow progenitor cells. However, STAT5B-DAM did not rescue the growth factor–independent colony formation of kinase-deficient K1172R BCR/ABL or the triple mutant Y177F+R522L+ Y793F BCR/ABL, both of which also fail to activate STAT5. Together, these data demonstrate that STAT5 activation by BCR/ABL is dependent on signaling from more than one domain and document the important role of STAT5-regulated pathways in BCR/ABL leukemogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Teglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., & Ihle, J. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81444-0 · Cited by 1,267
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S.-H., Ram, P. A., Waxman, D. J., & Davey, H. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7239 · Cited by 988
Lin, J.-X., Migone, T.-S., Tseng, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90141-8 · Cited by 752
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 672
Requirement of Serine Phosphorylation for Formation of STAT-Promoter Complexes
Zhang, X., Blenis, J., Li, H.-C., Schindler, C., & Chen-Kiang, S. (1995) · Science · doi:10.1126/science.7701321 · Cited by 573
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567 · cited 8×
“The pSR α p210BCR/ABL wild-type (WT) and the kinase-deficient K1172R, ∆ SH3, ∆ SH2, P1013L, and R1053L BCR/ABL mutants have been described previously (9, 21).”
InfluentialSelf-citationMatsumoto, A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M., Misawa, H., Miyajima, A., & Yoshimura, A. (1997) · Blood · doi:10.1182/blood.v89.9.3148 · Cited by 528
Greenberger, J. S., Sakakeeny, M. A., Humphries, R. K., Eaves, C. J., & Eckner, R. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.10.2931 · Cited by 526
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
Boccaccio, C., Andò, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., & Comoglio, P. M. (1998) · Nature · doi:10.1038/34657 · Cited by 519
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher, M. A., McLaughlin, J., Witte, O. N., & Rosenberg, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6649 · Cited by 514
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J., Sharkis, S., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 508
van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., & Berns, A. (1989) · Cell · doi:10.1016/0092-8674(89)90589-8 · Cited by 496
Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07100.x · Cited by 493
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.811 · Cited by 483
McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K., Green, D., & Cotter, T. (1994) · Blood · doi:10.1182/blood.v83.5.1179.1179 · Cited by 472
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 464
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., & Sawyers, C. L. (1996) · PubMed · Cited by 434
Onishi, M., Nosaka, T., Misawa, K., Mui, A. L.-F., Gorman, D., McMahon, M., Miyajima, A., & Kitamura, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3871 · Cited by 412
Self-citationSkorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M., Wen, S., Zon, G., Gewirtz, A., Perussia, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 404
Self-citationDominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 397
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Pendergast, A. M., Muller, A. J., Havlik, M. H., Maru, Y., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90148-r · Cited by 364
Lin, E. Y., Orlofsky, A., Berger, M. S., & Prystowsky, M. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.1979 · Cited by 335
Mui, A. L., Wakao, H., Kinoshita, T., Kitamura, T., & Miyajima, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00600.x · Cited by 330
Self-citationJak-STAT Signaling Induced by the v- abl oncogene
Danial, N. N., Pernis, A., & Rothman, P. B. (1995) · Science · doi:10.1126/science.7569929 · Cited by 325
Interleukin-3 signals through multiple isoforms of Stat5.
Azam, M., Erdjument-Bromage, H., Kreider, B. L., Xia, M., Quelle, F., Basu, R., Saris, C., Tempst, P., Ihle, J. N., & Schindler, C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07126.x · Cited by 323
Gouilleux-Gruart, V, Gouilleux, F., Desaint, C., Claisse, J., Capiod, J., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., et al. (1996) · Blood · doi:10.1182/blood.v87.5.1692.1692 · Cited by 316
Mayer, B. J., Jackson, P. K., Van Etten, R. A., & Baltimore, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.609 · Cited by 288
Chai, S. K., Nichols, G. L., & Rothman, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4720 · Cited by 280
Cortez, D., Kadlec, L., & Pendergast, A. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5531 · Cited by 267
Sawyers, C. L., McLaughlin, J., & Witte, O. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.307 · Cited by 253
Pim-1 Kinase and p100 Cooperate to Enhance c-Myb Activity
Leverson, J. D., Koskinen, P. J., Orrico, F. C., Rainio, E.-M., Jalkanen, K. J., Dash, A. B., Eisenman, R. N., & Ness, S. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80141-0 · Cited by 252
Naturally Occurring Dominant Negative Variants of Stat5
Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., & Ihle, J. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6141 · Cited by 252
Verfaillie, C. M., McCarthy, J. B., & McGlave, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115985 · Cited by 249
Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
Goga, A., McLaughlin, J., Afar, D. E. H., Saffran, D. C., & Witte, O. N. (1995) · Cell · doi:10.1016/0092-8674(95)90277-5 · Cited by 248
Waxman, D. J., Ram, P. A., Park, S.-H., & Choi, H. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13262 · Cited by 240
Expression of a Distinctive BCR-ABL Oncogene in Ph 1 -Positive Acute Lymphocytic Leukemia (ALL)
Clark, S. S., McLaughlin, J., Timmons, M., Pendergast, A. M., Ben-Neriah, Y., Dow, L. W., Crist, W., Rovera, G., Smith, S. D., & Witte, O. N. (1988) · Science · doi:10.1126/science.3422516 · Cited by 235
Amarante-Mendes, G. P., McGahon, A. J., Nishioka, W. K., Afar, D. E., Witte, O. N., & Green, D. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201664 · Cited by 226
Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M., & Wasik, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9148 · Cited by 221
Self-citationCortez, D., Reuther, G., & Pendergast, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201400 · Cited by 216
Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
Wakao, H., Harada, N., Kitamura, T., Mui, A. L., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07250.x · Cited by 210
Self-citationActivation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.
Varticovski, L., Daley, G. Q., Jackson, P., Baltimore, D., & Cantley, L. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1107 · Cited by 210
Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
Sánchez-García, I., & Grütz, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5287 · Cited by 192
Feldman, G. M., Rosenthal, L. A., Liu, X., Hayes, M. P., Wynshaw-Boris, A., Leonard, W. J., Hennighausen, L., & Finbloom, D. S. (1997) · Blood · doi:10.1182/blood.v90.5.1768 · Cited by 175
Han, L., & Colicelli, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1318 · Cited by 168
Davis, R. L., Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.204 · Cited by 151
A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation
Lin, E., Orlofsky, A., Wang, H., Reed, J., & Prystowsky, M. B. (1996) · Blood · doi:10.1182/blood.v87.3.983.bloodjournal873983 · Cited by 144
The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.
Cortez, D., Stoica, G., Pierce, J. H., & Pendergast, A. M. (1996) · PubMed · Cited by 138
Frank, D. A., & Varticovski, L. (1996) · PubMed · Cited by 133
Sirard, C., Laneuville, P., & Dick, J. E. (1994) · Blood · doi:10.1182/blood.v83.6.1575.1575 · Cited by 133
Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression
Klucher, K. M., Lopez, D. V., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.10.3927 · Cited by 122
Liu, L., Damen, J. E., Hughes, M. R., Babić, I., Jirik, F. R., & Krystal, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8983 · Cited by 119
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skórski, T., & Calabretta, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.1995 · Cited by 116
Self-citationSaharinen, P., Ekman, N., Sarvas, K., Parker, P. J., Alitalo, K. K., & Silvennoinen, O. (1997) · Blood · doi:10.1182/blood.v90.11.4341 · Cited by 115
Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
Sattler, M., & Salgia, R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00047-0 · Cited by 112
Kabarowski, J. H. S., Allen, P. B., & Wiedemann, L. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06934.x · Cited by 109
D’Sa-Eipper, C., Subramanian, T., & Chinnadurai, G. (1996) · PubMed · Cited by 108
Yu, C., Jove, R., & Burakoff, S. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5206 · Cited by 105
Chaturvedi, P., Sharma, S., & Reddy, E. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3295 · Cited by 104
Signal transduction by wild-type and leukemogenic Abl proteins
Raitano, A. B., Whang, Y. E., & Sawyers, C. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00023-1 · Cited by 102
Skórski, T., Kanakaraj, P., Ku, D.-H., Nieborowska-Skorska, M., Canaani, E., Zon, G., PERUSSIA, B., & Calabretta, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1855 · Cited by 98
Self-citationFunction and Signal Transduction Mediated by the Interleukin 3 Receptor System in Hematopoiesis
Hara, T., & Miyajima, A. (1996) · Stem Cells · doi:10.1002/stem.140605 · Cited by 95
Meyer, J., Jücker, M., Ostertag, W., & Stocking, C. (1998) · Blood · doi:10.1182/blood.v91.6.1901 · Cited by 91
BCR/ABL-mediated leukemogenesis requires the activity of the small GTP- binding protein Rac
Skorski, T., Wlodarski, P., Daheron, L., Salomoni, P., Nieborowska-Skorska, M., Majewski, M., Wasik, M., & Calabretta, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11858 · Cited by 89
Self-citationZamorano, J., Wang, H. Y., Wang, R., Shi, Y., Longmore, G. D., & Keegan, A. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3502 · Cited by 88
Boucheron, C., Dumon, S., Santos, S. C. R., Moriggl, R., Hennighausen, L. G., Gisselbrecht, S., & Gouilleux, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33936 · Cited by 86
Skórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Wasik, M. A., Trotta, R., Kanakaraj, P., Salomoni, P., Antonyak, M., Martinez, R., Majewski, M., et al. (1998) · Blood · doi:10.1182/blood.v91.2.406 · Cited by 86
Self-citationBlastic transformation of p53-deficient bone marrow cells by p210 bcr/abl tyrosine kinase
Skórski, T., Nieborowska-Skorska, M., Wlodarski, P. K., Perrotti, D., Martinez, R., Wasik, M. A., & Calabretta, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13137 · Cited by 84
Self-citationRegulation of the Oncogenic Activity of BCR-ABL by a Tightly Bound Substrate Protein RIN1
Afar, D., Han, L., McLaughlin, J., Wong, S., Dhaka, A., Parmar, K., Rosenberg, N. E., Witte, O. N., & Colicelli, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80452-5 · Cited by 80
Sattler, M., Salgia, R., Shrikhande, G., Verma, S., Choi, J., Rohrschneider, L. R., & Griffin, J. D. (1997) · Oncogene · doi:10.1038/sj.onc.1201422 · Cited by 78
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.
Skórski, T., Nieborowska-Skorska, M., Szczylik, C. A., Kanakaraj, P., Perrotti, D., Zon, G., Gewirtz, A. M., PERUSSIA, B., & Calabretta, B. (1995) · PubMed · Cited by 66
Self-citationDanial, N. N., Losman, J. A., Lu, T., Yip, N. H., Krishnan, K., Krolewski, J. J., Goff, S. P., Wang, J. Y. J., & Rothman, P. B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6795 · Cited by 63
Identification of Stat 5B as a Substrate of the Insulin Receptor
Sawka‐Verhelle, D., Filloux, C., Tartare‐Deckert, S., Mothe‐Satney, I., & OBBERGHEN, E. V. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0411a.x · Cited by 51
Sm, A., & Mladenovic, J. (1996) · Blood · doi:10.1182/blood.v87.1.238.bloodjournal871238 · Cited by 44
Molecular Genetic Advances in Chronic Myelogenous Leukemia
Epner, D. E., & Koeffler, H. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-1-3 · Cited by 43
Nam, H.-J., Haser, W. G., Roberts, T. M., & Frederick, C. (1996) · Structure · doi:10.1016/s0969-2126(96)00116-5 · Cited by 40
Davis, R. L., Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.204-213.1985 · Cited by 38
Cited by
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
“Constitutive STAT activation in these cells mimics many aspects of IL3-induced signaling such as mitogenesis and enhanced survival (Carlesso et al., 1996) and plays important roles in malignant transformation (de Groot et al., 1999; Nieborowska-Skorska et al., 1999).”
BackgroundThe role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
“…such as the BCR/ABL tyrosine kinase and HTLV-1 leads to persistent tyrosine phosphorylation of Stat5 (Migone et al., 1995; Shuai et al., 1996); and a Stat5 dominant negative protein in murine bone marrow cultures can abrogate cellular transformation by BCR/ABL (Nieborowska-Skorska et al., 1999).”
BackgroundSingle Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells
Irish, J. M., Hovland, R., Krutzik, P. O., Perez, O. D., Bruserud, Ø., Gjertsen, B. T., & Nolan, G. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.028 · Cited by 684
A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake
Devireddy, L. R., Gazin, C., Zhu, X., & Green, M. R. (2005) · Cell · doi:10.1016/j.cell.2005.10.027 · Cited by 672
Donato, N. J., Wu, J. Y., Stapley, J., Gallick, G., Lin, H., Arlinghaus, R., & Talpaz, M. (2003) · Blood · doi:10.1182/blood.v101.2.690 · Cited by 663
Metadata
- Authors
- Nieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., & Skorski, T.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-04-19
- Volume
- 189
- Issue
- 8
- Pages
- 1229-1242
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2104830066
- Cited by
- 271
- References
- 87
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.